Page 6 - 《中国药房》2026年9期
P. 6
Study on the influencing factors of venetoclax trough concentration and its association with efficacy in patients
with acute myeloid leukemia ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ HE Weiwei,LIU Zhirui,QIN Shiwei,GONG Qiang,CHENG Lin (1200)
Effect evaluation of pharmaceutical service based on root cause analysis combined with KAP theory on decreasing
the protocol violations of investigational medicinal products rate in pediatric clinical trials ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ GUO Chunyan,
ZHANG Yi,YANG Yuxin,LIANG Yuguang,DING Qian,WANG Qian,ZHANG Chengyue,SUN Yu,GUO Peng (1206)
Design and management scheme practice of intelligent drug shelf positioning software based on the “five-level
positioning” concept ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ XIANG Xinxin,YANG Mao,LI Weiping (1211)
Meta-analysis of the effects of different doses of vitamin D supplementation on maternal and infant outcomes in
vitamin D-deficient pregnant women ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ SHI Xiaoxia,WANG Weina,LI Rui,DU Yaheng,LIU Lu (1215)
Rapid health technology assessment of carfilzomib in the treatment of multiple myeloma ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ FENG Zhen,LAI Ran (1222)
Research progress on the intervention of sarcopenia with traditional Chinese medicine based on the AMPK
signaling pathway ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
FAN Wenyu,HUANG Bairong,HONG Congmin,CHEN Yan,WANG Jiayin,GAO Jing,FENG Xiaodong (1229)
New advances in the treatment of neonatal diabetes mellitus with sulfonylureas ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ HU Xiaoyan,
XIANG Jinbo,ZHU Xiaoxia,LI Zheng,CAO Tingting,DING Ting,XU Ziran,LI Jingbo,YANG Youjun (1236)
CHINA PHARMACY (Semimonthly) Postal Address
Founded in January 1990 Journal Center of Chongqing University Cancer Hospital
Vol.37, No.9, May 2026 129 Daping Main Street,Yuzhong District,Chongqing
Total No.819 Published on May 15,2026 400042,China
Phone
Responsible Institution +86-23-63830521;+86-23-63830907;+86-23-68586727;
National Health Commission,P.R. China +86-23-68586827;+86-23-68573988
Sponsored by E-mail
info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http://www.china-pharmacy.com
Published by Online Submission
China Pharmacy Editorial Department http://user.china-pharmacy.com
Director of Editorial Commission Printed by
TIAN Jiazheng Chongqing Changhong Printing Co., Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China: Chongqing Branch of China Post Group Co., Ltd.
Deputy Director of Editorial Commission (Code No.78-33)
WANG Ying;WANG Zhiqiang Overseas: China International Book Trading Corporation
Chief of Journal Center (Code No.4703SM)
Subscription Rates
ZOU Xiaoyong CNY 15 per issue;CNY 360 per annum
Editor-in-Chief ISSN 1001-0408
HU Xin CSSN CN 50-1055/R
Deputy Editor-in-Chief CODEN
LENG Huaiming;ZOU Xiaoyong ZYHAA4
Chief Editor Perennial Legal Counsel
XIA Peiyuan Chongqing Huali Wantao Law Firm

